OPN5 and cholangiocarcinoma: OPN-a, OPN-b, OPN-c, and OPN-5 are increased in renal papillary cell carcinoma, cholangiocarcinoma, hepatocellular carcinoma, lung adenocarcinoma, lung squamous cell carcinoma, as well as head and neck cancer.